CHURCH KEVIN 4
4 · Athira Pharma, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2024-10-01+110,000→ 110,000 totalExercise: $0.45Exp: 2034-09-30→ Common Stock (110,000 underlying) - Award
Restricted Stock Units
2024-10-01+110,000→ 110,000 total→ Common Stock (110,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.
- [F2]One-third (1/3rd) of the RSUs shall vest on each of December 31, 2024, June 30, 2025 and December 31, 2025, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan (the "Plan")) through the applicable vesting dates.
- [F3]One-third (1/3rd) of the shares subject to the option shall vest on each of December 31, 2024, June 30, 2025 and December 31, 2025, subject to the Reporting Person continuing to be a Service Provider through the applicable vesting dates.